{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:50:23Z","timestamp":1782564623037,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12158-2","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:42:58Z","timestamp":1782564178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rho GTPase-related prognostic signature for esophageal squamous cell carcinoma identifies CTTN as a candidate adverse prognostic marker"],"prefix":"10.1007","volume":"53","author":[{"given":"Hua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-er","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiancheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangkai","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"3","key":"12158_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2020","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2020) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"12158_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2020","unstructured":"Qiu H, Cao S, Xu R (2020) Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun 41(10):1037\u20131048. https:\/\/doi.org\/10.1002\/cac2.12197","journal-title":"Cancer Commun"},{"issue":"3","key":"12158_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J, Arnold M (2022) The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology 163(3):649-658.e2. https:\/\/doi.org\/10.1053\/j.gastro.2022.05.054","journal-title":"Gastroenterology"},{"issue":"2","key":"12158_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"CC Abnet","year":"2018","unstructured":"Abnet CC, Arnold M, Wei WQ (2018) Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology 154(2):360\u2013373. https:\/\/doi.org\/10.1053\/j.gastro.2017.08.023","journal-title":"Gastroenterology"},{"key":"12158_CR5","doi-asserted-by":"publisher","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","volume":"3","author":"EC Smyth","year":"2017","unstructured":"Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D (2017) Oesophageal cancer. Nat Rev Dis Primers 3:17048. https:\/\/doi.org\/10.1038\/nrdp.2017.48 PMID: 28748917; PMCID: PMC6168059","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"12158_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21332","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"12158_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global Cancer Incidence and Mortality Rates and Trends\u2013An Update. Cancer Epidemiol Biomarkers Prev 25(1):16\u201327. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0578","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"12158_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022152","volume":"6","author":"K Aghcheli","year":"2011","unstructured":"Aghcheli K, Marjani HA, Nasrollahzadeh D, Islami F, Shakeri R, Sotoudeh M, Abedi-Ardekani B, Ghavamnasiri MR, Razaei E, Khalilipour E, Mohtashami S, Makhdoomi Y, Rajabzadeh R, Merat S, Sotoudehmanesh R, Semnani S, Malekzadeh R (2011) Prognostic factors for esophageal squamous cell carcinoma\u2013a population-based study in Golestan Province, Iran, a high incidence area. PLoS One 6(7):e22152. https:\/\/doi.org\/10.1371\/journal.pone.0022152","journal-title":"PLoS One"},{"issue":"5","key":"12158_CR9","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.athoracsur.2003.10.098","volume":"77","author":"GQ Wang","year":"2004","unstructured":"Wang GQ, Jiao GG, Chang FB, Fang WH, Song JX, Lu N, Lin DM, Xie YQ, Yang L (2004) Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 77(5):1740\u20134. https:\/\/doi.org\/10.1016\/j.athoracsur.2003.10.098","journal-title":"Ann Thorac Surg"},{"issue":"6382","key":"12158_CR10","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science 359(6382):1350\u20131355. https:\/\/doi.org\/10.1126\/science.aar4060","journal-title":"Science"},{"issue":"9","key":"12158_CR11","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1111\/cas.14541","volume":"111","author":"Y Baba","year":"2020","unstructured":"Baba Y, Nomoto D, Okadome K, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Baba H (2020) Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma. Cancer Sci 111(9):3132\u20133141. https:\/\/doi.org\/10.1111\/cas.14541","journal-title":"Cancer Sci"},{"issue":"1","key":"12158_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","volume":"21","author":"AB Jaffe","year":"2005","unstructured":"Jaffe AB, Hall A (2005) Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21(1):247\u201369. https:\/\/doi.org\/10.1146\/annurev.cellbio.21.020604.150721","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"4","key":"12158_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/bies.20558","volume":"29","author":"XR Bustelo","year":"2007","unstructured":"Bustelo XR, Sauzeau V, Berenjeno IM (2007) GTP-binding proteins of the Rho\/Rac family: regulation, effectors and functions in vivo. BioEssays 29(4):356\u2013370. https:\/\/doi.org\/10.1002\/bies.20558 PMID: 17373658; PMCID: PMC1971132","journal-title":"BioEssays"},{"issue":"50","key":"12158_CR14","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1038\/s41388-019-0963-7","volume":"38","author":"JH Svensmark","year":"2019","unstructured":"Svensmark JH, Brakebusch C (2019) Rho GTPases in cancer: friend or foe? Oncogene 38(50):7447\u20137456. https:\/\/doi.org\/10.1038\/s41388-019-0963-7 Epub 2019 Aug 19. PMID: 31427738","journal-title":"Oncogene"},{"issue":"4","key":"12158_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/21541248.2017.1391365","volume":"11","author":"P Aspenstr\u00f6m","year":"2020","unstructured":"Aspenstr\u00f6m P (2020) Fast-cycling Rho GTPases. Small GTPases 11(4):248\u2013255. https:\/\/doi.org\/10.1080\/21541248.2017.1391365 Epub 2018 Jan 29. PMID: 29157138; PMCID: PMC7549678","journal-title":"Small GTPases"},{"issue":"8","key":"12158_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nrm.2016.67","volume":"17","author":"RG Hodge","year":"2016","unstructured":"Hodge RG, Ridley AJ (2016) Regulating Rho GTPases and their regulators. Nat Rev Mol Cell Biol 17(8):496\u2013510. https:\/\/doi.org\/10.1038\/nrm.2016.67 Epub 2016 Jun 15. PMID: 27301673","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"12158_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrm1587","volume":"6","author":"KL Rossman","year":"2005","unstructured":"Rossman KL, Der CJ, Sondek J (2005) GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6(2):167\u201380. https:\/\/doi.org\/10.1038\/nrm1587","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"12158_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","volume":"129","author":"JL Bos","year":"2007","unstructured":"Bos JL, Rehmann H, Wittinghofer A (2007) GEFs and GAPs: critical elements in the control of small G proteins. Cell 129(5):865\u201377. https:\/\/doi.org\/10.1016\/j.cell.2007.05.018","journal-title":"Cell"},{"issue":"8","key":"12158_CR19","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/1078-0432.CCR-14-3214","volume":"21","author":"AD Cox","year":"2015","unstructured":"Cox AD, Der CJ, Philips MR, Targeting RAS (2015) Membrane Association: Back to the Future for Anti-RAS Drug Discovery? Clin Cancer Res 21(8):1819\u20131827. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-3214 PMID: 25878363; PMCID: PMC4400837","journal-title":"Clin Cancer Res"},{"issue":"1","key":"12158_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1152\/physrev.00045.2020","volume":"102","author":"E Crosas-Molist","year":"2022","unstructured":"Crosas-Molist E, Samain R, Kohlhammer L, Orgaz JL, George SL, Maiques O, Barcelo J, Sanz-Moreno V (2022) Rho GTPase signaling in cancer progression and dissemination. Physiol Rev 102(1):455\u2013510 Epub 2021 Sep 20. PMID: 34541899","journal-title":"Physiol Rev"},{"issue":"4","key":"12158_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/21541248.2016.1232583","volume":"7","author":"RB Haga","year":"2016","unstructured":"Haga RB, Ridley AJ (2016) Rho GTPases: Regulation and roles in cancer cell biology. Small GTPases 7(4):207\u2013221. https:\/\/doi.org\/10.1080\/21541248.2016.1232583 Epub 2016 Sep 14. PMID: 27628050; PMCID: PMC5129894","journal-title":"Small GTPases"},{"issue":"6","key":"12158_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/sj.bjc.6600510","volume":"87","author":"G Fritz","year":"2002","unstructured":"Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B (2002) Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 87(6):635\u2013644. https:\/\/doi.org\/10.1038\/sj.bjc.6600510 PMID: 12237774; PMCID: PMC2364248","journal-title":"Br J Cancer"},{"issue":"6","key":"12158_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/bies.20238","volume":"27","author":"T G\u00f3mez del Pulgar","year":"2005","unstructured":"G\u00f3mez del Pulgar T, Benitah SA, Valer\u00f3n PF, Espina C, Lacal JC (2005) Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays 27(6):602\u201313. https:\/\/doi.org\/10.1002\/bies.20238","journal-title":"Bioessays"},{"issue":"14","key":"12158_CR24","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1158\/1078-0432.CCR-0436-03","volume":"10","author":"T Kamai","year":"2004","unstructured":"Kamai T, Yamanishi T, Shirataki H, Takagi K, Asami H, Ito Y, Yoshida K (2004) Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 10(14):4799\u2013805. https:\/\/doi.org\/10.1158\/1078-0432.CCR-0436-03","journal-title":"Clin Cancer Res"},{"issue":"7","key":"12158_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070733","volume":"8","author":"M Bros","year":"2019","unstructured":"Bros M, Haas K, Moll L, Grabbe S (2019) RhoA as a key regulator of innate and adaptive immunity. Cells 8(7):733. https:\/\/doi.org\/10.3390\/cells8070733","journal-title":"Cells"},{"issue":"7636","key":"12158_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature20805","volume":"541","author":"Kansas Medical Center","year":"2017","unstructured":"Kansas Medical Center, University of Michigan, University of North Carolina at Chapel Hill, University of Pittsburgh School of Medicine, University of Texas MD Anderson Cancer Center, Disease Working Group: Duke University, Memorial Sloan Kettering Cancer Center, National Cancer Institute, University of Texas MD Anderson Cancer Center, Yonsei University College of Medicine, Data Coordination Center: CSRA Inc., Project Team: National Institutes of Health (2017) Integrated genomic characterization of oesophageal carcinoma. Nature 541(7636):169\u2013175. https:\/\/doi.org\/10.1038\/nature20805","journal-title":"Nature"},{"issue":"1","key":"12158_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","volume":"63","author":"RC Fitzgerald","year":"2014","unstructured":"Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O\u2019Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J (2014) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett\u2019s oesophagus. Gut 63(1):7\u201342. https:\/\/doi.org\/10.1136\/gutjnl-2013-305372","journal-title":"Gut"},{"issue":"1","key":"12158_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00791-w","volume":"12","author":"Q Sun","year":"2022","unstructured":"Sun Q, Xu Y, Yuan F, Qi Y, Wang Y, Chen Q, Liu B (2022) Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma. Cell Biosci 12(1):53. https:\/\/doi.org\/10.1186\/s13578-022-00791-w","journal-title":"Cell Biosci"},{"issue":"13","key":"12158_CR29","doi-asserted-by":"publisher","first-page":"11180","DOI":"10.18632\/oncotarget.24358","volume":"9","author":"HL Lehman","year":"2018","unstructured":"Lehman HL, Kidacki M, Warrick JI, Stairs DB (2018) NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulation. Oncotarget 9(13):11180\u201311196. https:\/\/doi.org\/10.18632\/oncotarget.24358","journal-title":"Oncotarget"},{"issue":"3","key":"12158_CR30","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20140021","volume":"34","author":"L Tong","year":"2014","unstructured":"Tong L, Tergaonkar V (2014) Rho protein GTPases and their interactions with NF\u03baB: crossroads of inflammation and matrix biology. Biosci Rep 34(3):e00115. https:\/\/doi.org\/10.1042\/BSR20140021","journal-title":"Biosci Rep"},{"issue":"1","key":"12158_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12029-013-9550-2","volume":"45","author":"A Fakhrjou","year":"2014","unstructured":"Fakhrjou A, Niroumand-Oscoei SM, Somi MH, Ghojazadeh M, Naghashi S, Samankan S (2014) Prognostic value of tumor-infiltrating mast cells in outcome of patients with esophagus squamous cell carcinoma. J Gastrointest Cancer 45(1):48\u201353. https:\/\/doi.org\/10.1007\/s12029-013-9550-2","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"12158_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20019-0","volume":"11","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Chen Z, Han Y, Han L, Zou X, Zhou B, Hu R, Hao J, Bai S, Xiao H, Li WV, Bueker A, Ma Y, Xie G, Yang J, Chen S, Li H, Cao J, Shen L (2020) Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nature Communications 11(1):6268. https:\/\/doi.org\/10.1038\/s41467-020-20019-0","journal-title":"Nature Communications"},{"key":"12158_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00561","volume":"8","author":"HO Alsaab","year":"2017","unstructured":"Alsaab HO, Sau S, Alzhrani R, Tatiparti K, Bhise K, Kashaw SK, Iyer AK (2017) PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol 8:561. https:\/\/doi.org\/10.3389\/fphar.2017.00561","journal-title":"Front Pharmacol"},{"issue":"1","key":"12158_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14728222.2018.1413091","volume":"22","author":"M Chaker","year":"2018","unstructured":"Chaker M, Minden A, Chen S, Weiss RH, Chini EN, Mahipal A, Azmi AS (2018) Rho GTPase effectors and NAD metabolism in cancer immune suppression. Expert Opin Ther Targets 22(1):9\u201317. https:\/\/doi.org\/10.1080\/14728222.2018.1413091","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"12158_CR35","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/pcmr.12392","volume":"28","author":"HL Vu","year":"2015","unstructured":"Vu HL, Rosenbaum S, Purwin TJ, Davies MA, Aplin AE (2015) RAC1 P29S regulates PD-L1 expression in melanoma. Pigment Cell Melanoma Res 28(5):590\u2013598. https:\/\/doi.org\/10.1111\/pcmr.12392 PMID: 26176707; PMCID: PMC4675336","journal-title":"Pigment Cell Melanoma Res"},{"issue":"11","key":"12158_CR36","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1002\/1878-0261.12804","volume":"14","author":"F Meng","year":"2020","unstructured":"Meng F, Su Y, Xu B (2020) Rho-associated protein kinase-dependent moesin phosphorylation is required for PD-L1 stabilization in breast cancer. Mol Oncol 14(11):2701\u20132712. https:\/\/doi.org\/10.1002\/1878-0261.12804 Epub 2020 Oct 3. PMID: 32941674; PMCID: PMC7607174","journal-title":"Mol Oncol"},{"issue":"3","key":"12158_CR37","doi-asserted-by":"publisher","first-page":"e14571","DOI":"10.1016\/j.heliyon.2023.e14571","volume":"9","author":"S Zheng","year":"2023","unstructured":"Zheng S, Liu T, Li L, Liu Q, Huang C, Liang Y, Tan Y, Zhang L, Lu X (2023) SLC1A5, unrelated to prognosis, was associated with CD8\u2009+\u2009T-cell exclusion in the tumor microenvironment of squamous cell carcinoma. Heliyon 9(3):e14571 PMID: 36950604; PMCID: PMC10025928","journal-title":"Heliyon"},{"issue":"2","key":"12158_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massagu\u00e9","year":"2008","unstructured":"Massagu\u00e9 J (2008) TGFbeta in Cancer. Cell 134(2):215\u2013230. https:\/\/doi.org\/10.1016\/j.cell.2008.07.001 PMID: 18662538; PMCID: PMC3512574","journal-title":"Cell"},{"key":"12158_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.semcancer.2016.08.009","volume":"42","author":"G Cantelli","year":"2017","unstructured":"Cantelli G, Crosas-Molist E, Georgouli M, Sanz-Moreno V (2017) TGF\u0392-induced transcription in cancer. Semin Cancer Biol 42:60\u201369. https:\/\/doi.org\/10.1016\/j.semcancer.2016.08.009 Epub 2016 Aug 30. PMID: 27586372; PMCID: PMC6137079","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"12158_CR40","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.4049\/jimmunol.176.9.5637","volume":"176","author":"M Ito","year":"2006","unstructured":"Ito M, Minamiya Y, Kawai H, Saito S, Saito H, Nakagawa T, Imai K, Hirokawa M, Ogawa J (2006) Tumor-Derived TGF\u03b2-1 Induces Dendritic Cell Apoptosis in the Sentinel Lymph Node. J Immunol 176(9):5637\u201343. https:\/\/doi.org\/10.4049\/jimmunol.176.9.5637","journal-title":"J Immunol"},{"issue":"6","key":"12158_CR41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H (2019) Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Rev Clin Oncol 16(6):356\u2013371. https:\/\/doi.org\/10.1038\/s41571-019-0175-7","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"12158_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2249.2012.04657.x","volume":"171","author":"K Oleinika","year":"2013","unstructured":"Oleinika K, Nibbs RJ, Graham GJ, Fraser AR (2013) Suppression, subversion and escape: the role of regulatory T cells in cancer progression. Clin Exp Immunol 171(1):36\u201345. https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04657.x PMID: 23199321; PMCID: PMC3530093","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"12158_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119781","volume":"1871","author":"Y Liang","year":"2024","unstructured":"Liang Y, He S, Liu Q, Liu T, Tan Y, Peng T, Huang C, Lu X, Zheng S (2024) Vimentin, inversely correlating with infiltration of CD8\u2009+\u2009T lymphocytes, promotes nuclear translocation of PD-L1 in esophageal squamous cell carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1871(7):119781. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119781","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"issue":"2","key":"12158_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.tcb.2017.10.009","volume":"28","author":"M Schnoor","year":"2018","unstructured":"Schnoor M, Stradal TE, Rottner K, Cortactin (2018) Cell Functions of A Multifaceted Actin-Binding Protein. Trends Cell Biol 28(2):79\u201398. https:\/\/doi.org\/10.1016\/j.tcb.2017.10.009 Epub 2017 Nov 20. PMID: 29162307","journal-title":"Trends Cell Biol"},{"issue":"10","key":"12158_CR45","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1128\/mcb.11.10.5113-5124.1991","volume":"11","author":"H Wu","year":"1991","unstructured":"Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT (1991) Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol 11(10):5113\u20135124. https:\/\/doi.org\/10.1128\/mcb.11.10.5113-5124.1991 PMID: 1922035; PMCID: PMC361526","journal-title":"Mol Cell Biol"},{"key":"12158_CR46","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.1038\/sj.onc.1204783","volume":"20","author":"SA Weed","year":"2001","unstructured":"Weed SA, Parsons JT, Cortactin (2001) Coupling membrane dynamics to cortical actin assembly. Oncogene 20:6418\u20136434. https:\/\/doi.org\/10.1038\/sj.onc.1204783","journal-title":"Oncogene"},{"key":"12158_CR47","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1083\/jcb.138.4.913","volume":"138","author":"L Machesky","year":"1997","unstructured":"Machesky L, Hall A (1997) Role of Actin Polymerization and Adhesion to Extracellular Matrix in Rac- and Rho-induced Cytoskeletal Reorganization. J Cell Biol 138:913\u2013926. https:\/\/doi.org\/10.1083\/jcb.138.4.913","journal-title":"J Cell Biol"},{"issue":"1","key":"12158_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s43556-024-00176-0","volume":"5","author":"S Zheng","year":"2024","unstructured":"Zheng S, He S, Liang Y, Tan Y, Liu Q, Liu T, Lu X (2024) Understanding PI3K\/Akt\/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Mol Biomed 5(1):13. https:\/\/doi.org\/10.1186\/s43556-024-00176-0 PMID: 38616230; PMCID: PMC11016524","journal-title":"Mol Biomed"},{"key":"12158_CR49","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1242\/jcs.115.2.433","volume":"115","author":"A Delaguillaumie","year":"2002","unstructured":"Delaguillaumie A, Lagaudri\u00e8re-Gesbert C, Popoff MR, Conjeaud H (2002) Rho GTPases link cytoskeletal rearrangements and activation processes induced via the tetraspanin CD82 in T lymphocytes. J Cell Sci 115:433\u2013443. https:\/\/doi.org\/10.1242\/jcs.115.2.433","journal-title":"J Cell Sci"},{"issue":"1","key":"12158_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1083\/jcb.151.1.29","volume":"151","author":"SA Weed","year":"2000","unstructured":"Weed SA, Karginov AV, Schafer DA, Weaver AM, Kinley AW, Cooper JA, Parsons JT (2000) Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2\/3 complex. J Cell Biol 151(1):29\u201340. https:\/\/doi.org\/10.1083\/jcb.151.1.29","journal-title":"J Cell Biol"},{"issue":"6","key":"12158_CR51","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/hed.25632","volume":"41","author":"P Ramos-Garc\u00eda","year":"2019","unstructured":"Ramos-Garc\u00eda P, Gonz\u00e1lez-Moles M\u00c1, Ay\u00e9n \u00c1, Gonz\u00e1lez-Ruiz L, Ruiz-\u00c1vila I, Gil-Montoya JA (2019) Prognostic and clinicopathological significance of CTTN\/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Head Neck 41(6):1963\u20131978. https:\/\/doi.org\/10.1002\/hed.25632 Epub 2018 Dec 30. PMID: 30597652","journal-title":"Head Neck"},{"issue":"4","key":"12158_CR52","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1158\/1541-7786.MCR-18-0391","volume":"17","author":"SM Markwell","year":"2019","unstructured":"Markwell SM, Ammer AG, Interval ET, Allen JL, Papenberg BW, Hames RA, Casta\u00f1o JE, Schafer DA, Weed SA (2019) Cortactin Phosphorylation by Casein Kinase 2 Regulates Actin-Related Protein 2\/3 Complex Activity, Invadopodia Function, and Tumor Cell Invasion. Mol Cancer Res 17(4):987\u20131001. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0391 Epub 2019 Jan 4. PMID: 30610108; PMCID: PMC6445698","journal-title":"Mol Cancer Res"},{"key":"12158_CR53","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.12659\/msm.904124","volume":"23","author":"J He","year":"2017","unstructured":"He J, Ma G, Qian J, Zhu Y, Liang M, Yao N, Ding Q, Chen L, Liu X, Xia T, Wang S (2017) Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells. Med Sci Monit 23:1583\u20131596. https:\/\/doi.org\/10.12659\/msm.904124 PMID: 28364518; PMCID: PMC5386444","journal-title":"Med Sci Monit"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12158-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12158-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12158-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:42:59Z","timestamp":1782564179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12158-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12158"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12158-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University. Written informed consent was obtained from all patients prior to tissue collection and use of clinical data. All procedures involving human participants complied with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"1021"}}